Life Sciences

Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas

The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.

Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.

The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.

We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.

We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.

  1. 27 Aug 2018  |  Global

    Growth Insights for the Direct-to-Consumer Genetic Testing Market, Forecast to 2022

    Consumer Education and Exploring Alternative Markets Would Drive the Direct-to-Consumer Genetic Testing Market

    As healthcare evolves toward personalized solutions, everyday consumers are proactively taking responsibility for their health in ways unimaginable a decade ago. A direct-to-consumer genetic test (DTCGT) exemplifies this trend which can be purchased and used directly by consumers without the requirement of a prescription from a healthcare provider....

    $3,000.00
  2. 18 Jul 2018  |  Global

    US Medical Marijuana Market, Forecast to 2022

    Medical Cannabis Revenue will Overtake Recreational in the Next 4 Years

    The medical marijuana market is growing in the United States despite the fact that the Food and Drug Administration (FDA) has not yet approved any medical marijuana products. These marijuana-based products have not yet passed through the rigorous tests and clinical trials required for medical drug approvals in the United States. At the Federal le...

    $3,000.00
  3. 05 Jul 2018  |  Global

    Why Now is The Time for Interoperable Healthcare Solutions?

    Synopsis from World Café Discussions Held at Health IT Forum of Medica 2017

    Healthcare organizations face numerous challenges in today’s dynamic business environment, be it clinical, non-clinical or operational processes in hospitals. The industry is fundamentally focusing on digital transformational strategies, while increasing its investments in next-generation solutions such as clinical information systems, connected ...

    $1,500.00
  4. 29 Jun 2018  |  Global

    Novel Therapies for Rare and Genetic Diseases

    Unveiling One of the Most Promising Fields of Therapeutic Technology Synergy

    Recent advancement in the development of novel platforms of smart targeting small molecules, gene therapy, stem cell therapy, gene modification, and gene rectification technologies pose new prospects for therapies and cures for rare and genetic diseases. More than 80% of rare diseases are genetic in origin, so that gene and cell therapies are being...

    $4,950.00
  5. 06 Jun 2018  |  Global

    Cardiometabolic Diseases Market—Trends and Growth Opportunities, Forecast to 2022

    Shift Towards a 'Comprehensive Care Continuum' with the Adoption of Integrated Care Pathways that Combine Clinical Therapies with Wellness Programs

    Globally, cardiometabolic diseases are witnessing a consistent rise in prevalence every year, with hypertension and diabetes among the leading conditions. A rising population of hypertension is, in turn, leading to growing incidence of chronic heart failure with about 26 million cases of CHF globally. Although drug therapies are the first line of t...

    $4,950.00
  6. 05 Jun 2018  |  Global

    Anti-Aging Therapies and Services Market—Trends and Growth Opportunities, Forecast to 2022

    Focus on Integrative Solutions Combining Dietary Supplements and Aesthetic Solutions with Clinical Therapeutics as the Market Moves Toward a ‘Prevent-Manage-Repair’ Continuum

    The rapidly aging global population is placing immense pressure on healthcare systems across countries and regions. The improvement in life expectancy levels has created a large cohort of aged patients who suffer from one or more chronic diseases. Traditionally, the approach towards the management of this issue has been on ‘repair’, i.e., treat...

    $4,950.00
  7. 15 Feb 2018  |  Global

    Global Laboratory Products Purchasing Trends, 2017–2018

    An End User Perspective on Laboratory Spending Reveals Optimism for Growing 2018 Budgets

    Readers of one of Frost & Sullivan’s media partners were invited to participate in an online survey in July 2017 that centered around the state of their laboratories in 2017 and their expectations for 2018. Frost & Sullivan has conducted similar studies among the same targeted respondents since 2012. Where applicable, the study presents year-over...

    $1,500.00
  8. 06 Feb 2018  |  Global

    Growth Opportunities in Clinical Trial Data Management and eClinical Solutions Market, Forecast to 2020

    Digitization Presents Opportunities for Unified Cloud-based Platform Solutions to Optimize Clinical Trial Workflows

    The global clinical trial IT market is expected to grow from $2.63 billion in 2016 to $4.29 billion in 2020 at a compound annual growth rate (CAGR) of more than 13.0%. North America will continue to hold the largest market share (by revenue) in 2017, followed by Europe. Increasing clinical trial activities in the emerging Asia-Pacific markets and r...

    $4,950.00
  9. 29 Dec 2017  |  Global

    Antimicrobial Technologies for Enhanced Consumer Health

    Novel Microbicidal Platforms Likely to Transform the Future of Global Consumer Health

    Healthcare-associated infection (HAI) continues to be a significant global concern, hence there is growing research for developing new antimicrobial platforms that can significantly decrease the risk of microbial infections. While metallic ions continue to be one of the most potent antimicrobial technology platform, several new innovations across a...

    $4,950.00
  10. 29 Dec 2017  |  Global

    Emerging Sensor Technologies Transforming Medical Diagnostics

    The Optimal Synergy between Leading-edge Science and Medical Innovation

    TechVisions latest research service profiles innovations in sensing technologies and their impact on clinical diagnosis. The emergence of point of care (PoC) testing has necessitated compact, more portable testing kits, to replace laboratory testing. In the light of global epidemic outbreaks, there is also a greater need for high throughput testing...

    $4,950.00